French Transparency Commission Recognises Efficacy of Zonegran® (zonisamide) Monotherapy

Eisai Europe Limited [Pressemappe]
Hatfield, England (ots/PRNewswire) – Transparency advice for Zonegran(R) (zonisamide) monotherapy in the treatment of partial seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy, has been published by the … Lesen Sie hier weiter…

Leave a reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>